4D Molecular Therapeutics (NASDAQ:FDMT) Shares Gap Up Following Analyst Upgrade

4D Molecular Therapeutics, Inc. (NASDAQ: FDMT - Get Free Report)'s stock price gapped up before the market opened on Thursday after Royal Bank Of Canada raised their price target on the stock from $32.00 to $35.00. The stock had previously closed at $8.56, but opened at $9.94. Royal Bank Of Canada currently has an outperform rating